Skip to main content

Ozempic maker now worth more than $500B

By Axios  
   February 01, 2024

The company's value is more than $100 billion above Denmark's entire GDP, and the GLP-1 drugs could help its sales grow as much as 26% this year.

Full story


Get the latest on healthcare leadership in your inbox.